Skip to main content
. 2018 Nov 16;27(2):103–110. doi: 10.1136/ejhpharm-2018-001649

Figure 2.

Figure 2

Network comparisons of included studies in the analyses. The size of the nodes and the thickness of the lines are weighted according to the number of studies assessing each treatment and direct comparison. Numbers above and below the lines indicate studies and patients respectively. AMI, amifostine; CHL, chlorhexidine; CRY, cryotherapy; CTL, control; GLU, glutamine; GM-CSF, granulocyte-monocyte colony-stimulating factor; MIS, misoprostol; PFM, palifermin; SUC, sucralfate; ZIN, zinc sulphate.